Acumen Pharmaceuticals, Inc. (ABOS) Stock Profile — Insider Trades & Financials

Net Income-$25.1M

EPS$-1.59

Market Cap$189.9M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Daniel O'Connell

CEO & Executive Director

Company profile for Acumen Pharmaceuticals, Inc. (ABOS) stock, with a description, list of executives, contact details and other key facts.

Founded: 1996
Employees: 1
Headquarters: NEWTON, MA, United States
Website: acumenpharm.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-35.69%

ROA?

-20.47%

D/E Ratio?

0.74

📊

Profitability Ratios

Current Ratio?

4.07

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Sep 14, 2026 (in 160 days)

Annual Report (10-K) — Based on filing pattern

Sep 14, 2026

Predicted10-K

Mar 26, 2026

10-KQ4 20256d after period end

Mar 26, 2026

10-KFY 202585d after period end

Nov 12, 2025

10-QQ3 20255d after period end

Aug 12, 2025

10-QQ2 20254d after period end

May 13, 2025

10-QQ1 20256d after period end

Mar 27, 2025

10-KQ4 20243d after period end

Mar 27, 2025

10-KFY 202586d after period end

Nov 12, 2024

10-QQ3 20245d after period end

Loading company sections...

Acumen Pharmaceuticals, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness